check_circleStudy Completed
Hyperphosphatemia
Bayer Identifier:
15074
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Long-term study in Chronic Kidney Disease (Extension from Study 14817)
Trial purpose
The objective of this study is to investigate the safety and the effect on reduction of serum phosphate of long-term administration of lanthanum carbonate (BAY77-1931) 750 to 2250 mg in patients with hyperphosphatemia who completed the 8 week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study.
Key Participants Requirements
Sex
BothAge
20 - N/ATrial summary
Enrollment Goal
123Trial Dates
September 2010 - April 2013Phase
Phase 3Could I Receive a placebo
NoProducts
Fosrenol (Lanthanum Carbonate, BAY77-1931)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Wakayama Medical University Hospital | Wakayama, 641-8510, Japan |
Terminated | Osaka General Medical Center | Osaka, 558-8558, Japan |
Completed | Osaka Rosai Hospital | Sakai, 591-8025, Japan |
Completed | Osaka Saiseikai Nakatsu Hospital | Osaka, 530-0012, Japan |
Completed | Kitano Hospital | Osaka, 530-8480, Japan |
Completed | Okayama Saiseikai General Hospital | Okayama, 700-0013, Japan |
Completed | Kurashiki Central Hospital | Kurashiki, 710-8602, Japan |
Terminated | The Jikei University Hospital | Minato-ku, 105-8471, Japan |
Completed | Chubu Rosai Hospital | Nagoya, 455-8530, Japan |
Completed | Juntendo Tokyo Koto Geriatric Medical Center | Koto, 136-0075, Japan |
Completed | Fujisawa City Hospital | Fujisawa, 251-8550, Japan |
Completed | Narita Memorial Hospital | Toyohashi, 441-8021, Japan |
Completed | Kawashima Hospital | Tokushima, 770-0011, Japan |
Completed | Osaka City General Hospital | Osaka, 534-0021, Japan |
Terminated | NTT Medical Center Tokyo | Shinagawa, 141-8625, Japan |
Completed | Musashino Red Cross Hospital | Musashino, 180-8610, Japan |
Completed | Shonan Kamakura General Hospital | Kamakura, 247-8533, Japan |
Terminated | Kameda Clinic | Kamogawa, 296-0041, Japan |
Completed | Kainan Hospital | Yatomi, 498-8502, Japan |
Completed | Nagoya Daini Red Cross Hospital | Nagoya, 466-8650, Japan |
Completed | Kyushu Medical Center | Fukuoka, 810-8563, Japan |
Completed | Kyoto Medical Center | Kyoto, 612-8555, Japan |
Completed | Beppu Medical Center | Beppu, 874-0011, Japan |
Completed | Oita Medical Center | Oita, 870-0263, Japan |
Completed | Nagoya Medical Center | Nagoya, 460-0001, Japan |
Completed | Tokyo Medical Center | Meguro-ku, 152-8902, Japan |
Completed | Shizuoka Tokushukai Hospital | Shizuoka, 421-0193, Japan |
Terminated | Social Insurance Chukyo Hospital | Nagoya, 457-8510, Japan |
Completed | Tosei General Hospital | Seto, 489-8642, Japan |
Terminated | Fukuoka University Hospital | Fukuoka, 814-0180, Japan |
Completed | Saga Prefectural Hospital Koseikan | Saga, 840-0054, Japan |
Completed | Hokkaido Medical Center | Sapporo, 063-0005, Japan |
Completed | Kimitsu Chuo Hospital | Kisarazu, 292-8535, Japan |
Completed | Kokura Memorial Hospital | Kitakyushu, 802-0001, Japan |
Completed | National Fukuoka-Higashi Medical Center | Koga, 811-3195, Japan |
Completed | Hyogo Prefectural Amagasaki Hospital | Amagasaki, 660-0828, Japan |
Completed | Saiseikai Yokohamashi Nanbu Hospital | Yokohama, 234-8503, Japan |
Terminated | Saiseikai Yahata General Hospital | Kitakyushu, 805-0050, Japan |
Completed | Yokohama City Minato Red Cross Hospital | Yokohama, 231-8682, Japan |
Completed | Anjo Kosei Hospital | Anjo, 446-8602, Japan |
Primary Outcome
- Incidence of treatment emergent adverse eventsdate_rangeTime Frame:baseline to Week 60enhanced_encryptionYesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
N/ABlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1